On that day, Yang Ping gathered his team members.
Yang Ping briefly introduced Alina's condition: 27 years old, MSH2 mutation, multiple adenomas, refused preventive surgery, requested to try a systematic regulatory K therapy.
Then he got straight to the point: "Should we use a regulation theory-based intervention on this Lynch Syndrome carrier who has not yet developed cancer, with the aim of preventing cancer?"
"The standard treatment is surgery," Song Zimo spoke first, "She refuses standard treatment and opts for experimental intervention; is this ethically permissible?"
